240 related articles for article (PubMed ID: 34455628)
1. A multiscale approach to predict the binding mode of metallo beta-lactamase inhibitors.
Gervasoni S; Spencer J; Hinchliffe P; Pedretti A; Vairoletti F; Mahler G; Mulholland AJ
Proteins; 2022 Feb; 90(2):372-384. PubMed ID: 34455628
[TBL] [Abstract][Full Text] [Related]
2. Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes.
Hinchliffe P; González MM; Mojica MF; González JM; Castillo V; Saiz C; Kosmopoulou M; Tooke CL; Llarrull LI; Mahler G; Bonomo RA; Vila AJ; Spencer J
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3745-54. PubMed ID: 27303030
[TBL] [Abstract][Full Text] [Related]
3. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
[TBL] [Abstract][Full Text] [Related]
4. 2-Mercaptomethyl Thiazolidines (MMTZs) Inhibit All Metallo-β-Lactamase Classes by Maintaining a Conserved Binding Mode.
Hinchliffe P; Moreno DM; Rossi MA; Mojica MF; Martinez V; Villamil V; Spellberg B; Drusano GL; Banchio C; Mahler G; Bonomo RA; Vila AJ; Spencer J
ACS Infect Dis; 2021 Sep; 7(9):2697-2706. PubMed ID: 34355567
[TBL] [Abstract][Full Text] [Related]
5. A close look onto structural models and primary ligands of metallo-β-lactamases.
Raczynska JE; Shabalin IG; Minor W; Wlodawer A; Jaskolski M
Drug Resist Updat; 2018 Sep; 40():1-12. PubMed ID: 30466711
[TBL] [Abstract][Full Text] [Related]
6. In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors.
Cain R; Brem J; Zollman D; McDonough MA; Johnson RM; Spencer J; Makena A; Abboud MI; Cahill S; Lee SY; McHugh PJ; Schofield CJ; Fishwick CWG
J Med Chem; 2018 Feb; 61(3):1255-1260. PubMed ID: 29271657
[TBL] [Abstract][Full Text] [Related]
7. Faropenem reacts with serine and metallo-β-lactamases to give multiple products.
Lucic A; Hinchliffe P; Malla TR; Tooke CL; Brem J; Calvopiña K; Lohans CT; Rabe P; McDonough MA; Armistead T; Orville AM; Spencer J; Schofield CJ
Eur J Med Chem; 2021 Apr; 215():113257. PubMed ID: 33618159
[TBL] [Abstract][Full Text] [Related]
8. Approaches for the discovery of metallo-β-lactamase inhibitors: A review.
Shi C; Chen J; Kang X; Shen X; Lao X; Zheng H
Chem Biol Drug Des; 2019 Aug; 94(2):1427-1440. PubMed ID: 30925023
[TBL] [Abstract][Full Text] [Related]
9. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.
Palacios AR; Rossi MA; Mahler GS; Vila AJ
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32503337
[TBL] [Abstract][Full Text] [Related]
10. Cyclic Boronates Inhibit All Classes of β-Lactamases.
Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor.
Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS
Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977
[TBL] [Abstract][Full Text] [Related]
12. Metallo-β-lactamase inhibitors: A continuing challenge for combating antibiotic resistance.
Kang SJ; Kim DH; Lee BJ
Biophys Chem; 2024 Jun; 309():107228. PubMed ID: 38552402
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamic simulations of the metallo-beta-lactamase from Bacteroides fragilis in the presence and absence of a tight-binding inhibitor.
Salsbury FR; Crowder MW; Kingsmore SF; Huntley JJ
J Mol Model; 2009 Feb; 15(2):133-45. PubMed ID: 19039608
[TBL] [Abstract][Full Text] [Related]
14. Structure and Molecular Recognition Mechanism of IMP-13 Metallo-β-Lactamase.
Softley CA; Zak KM; Bostock MJ; Fino R; Zhou RX; Kolonko M; Mejdi-Nitiu R; Meyer H; Sattler M; Popowicz GM
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32205343
[TBL] [Abstract][Full Text] [Related]
15. Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7.
Bergstrom A; Katko A; Adkins Z; Hill J; Cheng Z; Burnett M; Yang H; Aitha M; Mehaffey MR; Brodbelt JS; Tehrani KHME; Martin NI; Bonomo RA; Page RC; Tierney DL; Fast W; Wright GD; Crowder MW
ACS Infect Dis; 2018 Feb; 4(2):135-145. PubMed ID: 29091730
[TBL] [Abstract][Full Text] [Related]
16. A modified bonded model approach for molecular dynamics simulations of New Delhi Metallo-β-lactamase.
Eshtiwi AA; Rathbone DL
J Mol Graph Model; 2023 Jun; 121():108431. PubMed ID: 36827734
[TBL] [Abstract][Full Text] [Related]
17. Metallo-β-lactamase-mediated antimicrobial resistance and progress in inhibitor discovery.
Yang Y; Yan YH; Schofield CJ; McNally A; Zong Z; Li GB
Trends Microbiol; 2023 Jul; 31(7):735-748. PubMed ID: 36858862
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the subclass B3 metallo-β-lactamase SMB-1 and the mode of inhibition by the common metallo-β-lactamase inhibitor mercaptoacetate.
Wachino J; Yamaguchi Y; Mori S; Kurosaki H; Arakawa Y; Shibayama K
Antimicrob Agents Chemother; 2013 Jan; 57(1):101-9. PubMed ID: 23070156
[TBL] [Abstract][Full Text] [Related]
19. Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers.
Brem J; van Berkel SS; Zollman D; Lee SY; Gileadi O; McHugh PJ; Walsh TR; McDonough MA; Schofield CJ
Antimicrob Agents Chemother; 2016 Jan; 60(1):142-50. PubMed ID: 26482303
[TBL] [Abstract][Full Text] [Related]
20. Progress toward inhibitors of metallo-β-lactamases.
McGeary RP; Tan DT; Schenk G
Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
